0001209191-14-022670.txt : 20140324 0001209191-14-022670.hdr.sgml : 20140324 20140324163021 ACCESSION NUMBER: 0001209191-14-022670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140320 FILED AS OF DATE: 20140324 DATE AS OF CHANGE: 20140324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van Deventer Sander CENTRAL INDEX KEY: 0001543084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 14713473 MAIL ADDRESS: STREET 1: POSTBUS 5187 CITY: NAARDEN STATE: P7 ZIP: 1410 AD 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-03-20 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001543084 van Deventer Sander C/O FORBION CAPITAL PARTNERS, GOOIMEER 2-35 NAARDEN P7 1411 DC NETHERLANDS 1 0 1 0 Stock Option (right to buy) 11.09 2014-03-20 4 A 0 11000 0.00 D 2024-03-19 Common Stock 11000 11000 D This option was granted on March 20, 2014 and vests in equal amounts quarterly over the three year period beginning on February 6, 2014. /s/ Lori Harrelson, as attorney-in-fact 2014-03-24